AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Amlodipine Besilate Equivalent To Amlodipine

9 registrations across 1 African market— 9 active

Markets with Amlodipine Besilate Equivalent To Amlodipine

Recent registrations

Brand / ProductMarketHolderStatusExpires
GEMVALAZ CO 5/160/25 mg🇿🇦South AfricaRanbaxy (SA) (Pty) LtdactiveJan 2029
GEMVALAZ CO 10/160/25 mg🇿🇦South AfricaRanbaxy (SA) (Pty) LtdactiveJan 2029
GEMVALAZ CO 10/320/25 mg🇿🇦South AfricaRanbaxy (SA) (Pty) LtdactiveJan 2029
VALGAMEZ CO 10/160/12,5 mg🇿🇦South AfricaRanbaxy (SA) (Pty) LtdactiveJan 2029
VALGAMEZ CO 10/160/25 mg🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdactiveJan 2029
VALGAMEZ CO 10/320/25 mg🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdactiveJan 2029
GEMVALAZ CO 5/160/12,5 mg🇿🇦South AfricaRanbaxy (SA) (Pty) LtdactiveJan 2029
GEMVALAZ CO 10/160/12,5 mg🇿🇦South AfricaRanbaxy (SA) (Pty) LtdactiveJan 2029
VALGAMEZ CO 5/160/25 mg🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdactiveJan 2029

Amlodipine Besilate Equivalent To Amlodipine in Africa — Regulatory Overview

Amlodipine Besilate Equivalent To Amlodipine is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.